Pfizer’s Comirnaty: Emerging Myocarditis Signal Drew Flurry Of Attention During Compressed BLA Review

Drug Review Profile: Comirnaty
US FDA's Review of Pfizer/BioNTech SE’s COVID-19 vaccine became unexpectedly more complicated mid-cycle with the emergence the myocarditis side effect.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Review Profiles

More from Product Reviews